|
Tobacco and Nicotine Research Interest Group (TANRIG)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, SAMHSA
|
NIDA, NCI, NHGRI, NHLBI, NIAAA, NIAID, NICHD, NIEHS, NIMH, NINR, OD/DPCPSI/OBSSR
|
The Tobacco and Nicotine Research Interest Group (TANRIG) was formed in January 2003 with the goal of increasing collaboration, coordination, and communication of tobacco- and nicotine-related research among National Institutes of Health Institutes and Centers, as well as with other relevant U.S. Department of Health and Human Services agencies.
|
|
Tobacco Regulatory Science Conference
|
Meeting/ Workshop
|
CDC, FDA
|
OD/DPCPSI/ODP, CSR, NCI, NHLBI, NIA, NIDA, NIDCD, NIDCR, NIMHD
|
The goal of the conference was to provide an overview of the field and a forum for researchers to identify areas of potential collaboration to advance tobacco regulatory science. The conference format included opportunities for researchers to hear from public health leadership, interact and explore contemporary topics in breakout sessions, and present the latest in tobacco regulatory science in poster/networking sessions.
|
|
Tobacco Regulatory Science Program (TRSP)
|
Research Initiative
|
FDA
|
OD/DPCPSI/ODP, NCI, OD/OER
|
Located in the National Institutes of Health (NIH) Office of Disease Prevention, the Tobacco Regulatory Science Program (TRSP) coordinates the trans-NIH collaborative effort with the U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP) to conduct research to support its regulatory activities over tobacco products. Within the framework of the Tobacco Control Act, the NIH and FDA formed an interagency partnership to foster tobacco regulatory research. The NIH has the infrastructure for the solicitation, review, and management of research. The FDA has expertise in tobacco regulatory science and the authority and resources to support research responsive to FDA’s regulatory authority. Support from FDA was used to fund grants and to provide administrative support and oversight to manage Funding Opportunity Announcements (FOA), application review, policy implementation and oversight, and communicating and reporting to a variety of sources.
|
|
Topic Refinement Panel for Renal Artery Stenosis AHRQ and Duke University Evidence-based Practice Center
|
Committee, Work group, Advisory group, or Task Force
|
CDC, HRSA
|
NHLBI
|
The Duke University Evidence-Based Practice Center (EPC) is working with the Agency for Healthcare Research and Quality (AHRQ) to conduct an update of their 2006 comparative effectiveness review on the topic of Treatment of Renal Artery Stenosis. The Technical Expert Panel (TEP) members provide expertise in the project research area to support the team of EPC investigators. TEP participation consists of attending 1-2 teleconferences over the course of roughly 12 months to discuss the protocol, key questions, analytical framework, literature search strategy, and other project-specific questions regarding report structure and data to be abstracted from the literature for inclusion in the report.
|
|
Tox21 - Memorandum of Understanding on High Throughput Screening, Toxicity Pathway Profiling, and Biological Interpretation of Findings
|
Research Initiative
|
FDA
|
NIEHS, NCATS
|
This Memorandum of Understanding sets in place mechanisms to strengthen existing collaborations in the research, development, validation, and translation of new and innovative test methods that characterize key steps in toxicity pathways. Central is the exploration of high throughput screening assays and tests using phylogenetically lower animal species as well as high throughput whole genome analytical methods, to evaluate mechanisms of toxicity. Ultimately, the data generated by these new tools is to be provided to risk assessors to use in the protection of human health and the environment. Success is expected to result in test methods for toxicity testing that are more scientifically and economically efficient and models for risk assessment that are more biologically based.
|
|
Toxicity of Subchronic Fungal Exposures
|
Research Initiative
|
CDC
|
NIEHS
|
The overall goal in this project is to better characterize the hazards associated with personal exposure to common fungal contaminants in indoor and occupational environments. These studies will advance the understanding of the toxicological and pulmonary immune responses associated with subchronic natural fungal exposures. The data derived from these toxicology studies will further our understanding of the relevant species that are capable of eliciting adverse health effects. To address these aims, NIOSH will utilize an innovative acoustical generation system and state-of-the-art methodologies to characterize toxicological endpoints following subchronic dry fungal spore and particle exposures. In addition, these studies will characterize the pulmonary immune responses to fungal contaminants nominated by the NTP.
|
|
Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR)
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
NIAID
|
The presidential declaration issued at the 2009 EU-US summit called for the creation of “a transatlantic task force on urgent antimicrobial resistance issues focused on appropriate therapeutic use of antimicrobial drugs in the medical and veterinary communities, prevention of both healthcare- and community-associated drug-resistant infections, and strategies for improving the pipeline of new antimicrobial drugs, which could be better addressed by intensified cooperation between us.” The objectives of the Trans-Atlantic Task Force on Antimicrobial Resistance (TATFAR) are to increase the mutual understanding of U.S. and EU activities and programs relevant to the antimicrobial resistance issues identified in the declaration to deepen the transatlantic dialogue, provide opportunities to learn from each other, and promote information exchange, coordination and co-operation.
|
|
Trans-HHS Interest Group on Intimate Partner Violence and Substance Abuse
|
Committee, Work group, Advisory group, or Task Force
|
ACF, CDC, IHS, SAMHSA
|
NIDA, NIAAA, NICHD, NIMH
|
Initiated and led by National Institute on Drug Abuse (NIDA) and co-hosted by Substance Abuse Mental Health Services Administration (SAMHSA), this interest group was established in June 2014 during which the participants discussed their agencies involvement and interest in this area and plans for filling the gaps that exist in research. The idea was initiated after interest that arose from many participants of the 2013 HHS IPV Symposium co-chaired by NIDA.
|
|
Trans-HHS Intimate Partner Violence Screening and Counseling: Research Symposium
|
Meeting/ Workshop
|
ACF, ACL, AHRQ, CDC, HRSA, IHS, SAMHSA
|
NIDA, NIA, NIAAA, NIMH, NLM, OD/DPCPSI/ORWH, OD/OER
|
The Coordinating Committee on Women''s Health represents agencies and offices throughout the Department of Health and Human Services (HHS). It has identified the prevention and intervention of domestic/intimate partner violence (IPV) as a priority focus for its cross-federal work. There is a critical need for guidelines for health practitioners to effectively screen patients for IPV and provide appropriate counseling. At the request of Dr. Howard Koh, HHS convened a research symposium at the National Institutes of Health (NIH) on Monday December 9, 2013 with the purpose of identifying gaps in research in screening and counseling for IPV in primary health care settings and to shape priorities in the national research agenda moving forward. Ultimately, the Department’s goal is to promote effective strategies for health care practitioners for screening and counseling.
|
|
Trans-NIH American Indian and Alaska Native Health Communications and Information Workgroup
|
Committee, Work group, Advisory group, or Task Force
|
ACL, IHS
|
NIAMS, CC, NCCAM, NCI, NEI, NHGRI, NHLBI, NIA, NIAAA, NICHD, NIDA, NIDCD, NIDCR, NIDDK, NIEHS, NIGMS, NIMH, NIMHD, NINDS, NINR, NLM, OD/DPCPSI/ORWH, OD/OCPL
|
Formed in 2005, the Trans-NIH AI/AN Health Communications and Information Work Group provides a forum for health education and communications staff from National Institutes of Health (NIH) Institutes, Centers, and Offices to share strategies and effective communication approaches to develop and disseminate health information to American Indian and Alaska Native communities. In partnership with the Indian Health Service (IHS) and the Administration on Aging/Administration for Community Living (AoA/ACL), the Work Group conducts outreach to 1,600 IHS Community Health Representatives (CHRs) and 600 AoA/ACL Title VI grantees nationwide through quarterly e-newsletters featuring NIH health information. The purpose of the project is to increase awareness among CHRs and Title VI grantees about the availability of free or low-cost, science-based health information for patients and the general public.
|